Shrydus Industries Rights Issue is scheduled on 5 – 19 Aug 2024
Incorporated in 1983, Shrydus Industries operates in the healthcare, real estate, and pharmaceutical sectors. The company now operates a pharmaceutical manufacturing plant in Gujarat, India. This plant produces tablets and capsules for export and has over 468 registered products. Despite the challenges posed by the global pandemic, the plant has demonstrated resilience and remains committed to delivering high-quality products. It is also equipped to manufacture various types of medications. The plant holds approvals from the National Drug Authorities of several East African countries and serves Uganda, Tanzania, Kenya, Ethiopia, Congo, and Malawi.
The plant can produce approximately 20 million tablets and 4 million capsules daily, including various pharmaceutical products. It is strategically located near major pharmaceutical players like Zydus, Cadilla, and Intas, leveraging its position in the pharmaceutical hub. As of March 2024, the company has 18 full-time employees.
Promoters of Shrydus Industries – Mr. Shrey Premal Parekh, and Mr. Vijay Thakordas Champaneri
Shrydus Industries Rights Issue Details
Shrydus Industries Rights Issue Date | 5 – 19 Aug 2024 |
Shrydus Industries Rights Issue Price | INR 18 per share |
Issue Size (in Shares) | 2,00,08,810 shares |
Issue Size (in INR) | INR 36.02 crore |
Issue Entitlement | 5 equity shares for every 3 equity shares held on record date |
Terms of Payment | Fully payable at the time of application |
Shrydus Industries Rights Issue Record Date | 19 July 2024 |
Face Value | INR 10 per share |
Listing On | BSE |
Shrydus Industries Rights Issue Calculation
Shrydus Industries Rights Issue Price | INR 18 per share |
Market Price on Rights Issue Approval | INR 19.29 per share |
Dilution Factor (X) | 2.67 |
Fair Value After Dilution at Prevailing Price | INR 18.48 per share |
Shrydus Industries Financial Performance
 | FY 2022 | FY 2023 | FY 2024 |
Revenue | 9.00 | 9.29 | 9.45 |
Expenses | 8.94 | 9.02 | 8.93 |
Operating Margin (%) | 0.67 | 2.91 | 5.50 |
Net Income | 0.05 | 0.30 | 0.52 |
ROCE (%) | 3.59 | 9.35 | – |
Shrydus Industries Rights Offer Objectives
The net proceeds from the offer are proposed to be used for
- Acquisition of Astra Lifecare (India) Private Limited – INR 15.68 crore
- Repayment of Loan availed from the related party through conversion outstanding Loan to Equity – INR 9.32 crore
- To Meet the working capital of the company – INR 8 crore
- Issue-related expenses – INR 0.60 crore
- General corporate purposes – INR 2.42 crore
Shrydus Industries Rights Offer Documents
Shrydus Industries Rights Issue Dates
Rights Issue Approval Date | 8 July 2024 |
Rights Issue Record Date | 19 July 2024 |
Credit of Rights Entitlement | Coming soon |
Rights Issue Opening Date | 5 August 2024 |
Last Date for Market Renunciation | 14 August 2024 |
Rights Issue Closing Date | 19 August 2024 |
Finalization of Basis of Allotment | Coming soon |
Rights Allotment Date | Coming soon |
Credit Date | Coming soon |
Listing Date | Coming soon |
Shrydus Industries Rights Offer Registrar
SKYLINE FINANCIAL SERVICES PRIVATE LIMITED
D-153 A, 1st Floor, Okhla Industrial Area,
Phase – I, New Delhi-110020
Telephone:Â +011-40450193-197
Email: [email protected]
Website:Â www.skylinerta.com
SHRYDUS INDUSTRIES LIMITED
107 Sagar Avenue Above Bata,
SV Road Andheri West, Andheri Railway Station,
Mumbai, Maharashtra, India, 400058
Phone:Â +91 9892710929
E-mail: [email protected]
Website:Â www.shrydus.com
Shrydus Industries Rights Offer FAQs
What is the Shrydus Industries Rights Issue Price?
The issue price is INR 18 per share.
What is the Shrydus Industries Rights Issue entitlement ratio?
The eligible shareholders are offered 5 Equity Shares for every 3 Equity Shares held on the record date.
What is the Shrydus Industries Rights Issue Record Date?
The Record date is 19 July 2024.
How to Apply for the Shrydus Industries Rights Offer?
The best way to apply for the Shrydus Industries Rights Offer is through Internet banking ASBA. You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an application Form form and deposit the same to your broker.